South African Covid virus variant
Date: 04 February 2021 Tags: MiscellaneousIssue
The WHO has identified three new variants of coronavirus originating in the UK, Brazil, and now in South Africa.
Background
Ever since scientists started tracking the SARS-CoV-2 virus that causes COVID-19, it has become a cause for concern that the virus has developed multiple variants.
Details
-
These newer strains are more contagious and could render vaccine and antibody protection less effective and thereby, spread rapidly across dozens of countries in a short span of time.
-
The latest South African variant known as 20H/501Y.V2 or B.1.351, is different from the one in Britain and appears to be more infectious than the original virus.
-
This potentially more concerning variant has been spotted since December 22 last year and emerged independently of B.1.1.7 or the UK variant and shares some mutations with the same.
-
The South African variant carries a mutation called N501Y that appears to make it more contagious or easy to spread.
-
South African researchers believe the new strain is around 50 percent more contagious than the previous variants.
-
The WHO has called for more studies on the new strain and it stressed that observational studies in South Africa did not indicate an increased risk of reinfection.
-
This South African variant has become a major cause of worry for the scientists because of its unusually large number of mutations, especially in the spike protein.
-
Notably, the spike protein is also the part of the virus targeted by Covid-19 vaccines and antibody treatments.
-
Another mutation of the South African variant called E484K, which is not found in the UK strain, is said to help the virus dodge attack by a person’s immune system and hamper the effectiveness of Covid-19 vaccines.
-
However, there is no evidence that Covid-19 vaccines that have been approved won’t work against the new strain.
-
Human clinical trials in South Africa suggest decreased efficiency of these vaccines as against the older variants.